![]() |
市场调查报告书
商品编码
1773348
婴儿奶粉市场机会、成长动力、产业趋势分析及2025-2034年预测Baby Milk Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球婴儿奶粉市场规模为 165 亿美元,预计到 2034 年将以 5.4% 的复合年增长率增长至 277 亿美元。这个市场有助于支持婴儿营养,特别是对于无法或选择不哺乳的母亲。奶粉种类繁多,包括婴儿配方奶粉(适用于 6 个月以下的婴儿)、较大婴儿配方奶粉(6 至 12 个月)、成长奶粉(12 至 36 个月),以及针对乳糖不耐症、早产和其他敏感健康需求开发的专用产品。这些乳製品经过科学配製,可模拟母乳,提供健康成长所必需的营养素,例如碳水化合物、脂肪、蛋白质、维生素和矿物质。职业母亲比例的提高、透过数位和零售平台获取产品管道的便利性以及人们对清洁标籤和有机替代品日益增长的兴趣,共同推动了市场的发展势头。
不断变化的消费者偏好正在重塑婴儿奶粉类别,促使企业提供安全、高效、营养丰富的选择,以符合注重健康的育儿理念。现今的育儿者不仅追求基本的营养,更越来越关注产品透明度、清洁标籤、有机采购以及不含人工添加剂。这种转变促使製造商不断改进产品配方,添加非基因改造成分、有益于肠道健康的益生菌,以及针对乳糖不耐症、过敏或早产等特殊需求的配方。如今,父母拥有更丰富的讯息,并要求产品拥有临床研究和医学认证的支援。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 165亿美元 |
预测值 | 277亿美元 |
复合年增长率 | 5.4% |
婴儿配方奶粉市场在2024年占据40.2%的市场份额,预计到2034年将保持领先地位,复合年增长率达5.6%。在婴儿出生后的最初六个月,父母非常依赖这个市场,因为此时婴儿最脆弱,需要精心均衡的营养方案。这些配方奶粉旨在提供全面的营养,与母乳中的关键营养成分非常接近。随着护理人员健康意识的不断提高,对高品质且经医学认证的婴儿配方奶粉的需求仍然是该类别的强劲驱动力,尤其是在城市家庭中。
碳水化合物细分市场在2024年占据28.1%的份额,预计到2034年将以5.5%的复合年增长率成长。乳糖是大多数婴儿配方奶粉中的主要碳水化合物,是重要的能量来源,并支持大脑发育和肠道菌丛健康等重要功能。它还有助于增强钙的吸收,促进骨骼发育。虽然蛋白质、维生素、脂肪和益生元等其他成分对免疫防御、代谢功能和组织修復至关重要,但碳水化合物因其对婴儿生长发育的基础性贡献而始终占据核心地位。它们与其他营养素的协同作用,凸显了其在产品配方中持续占据重要地位。
2024年,美国婴儿奶粉市场规模达39亿美元,预计2034年将以4.4%的复合年增长率成长。美国拥有成熟的配方奶粉生产产业、广泛的产品可及性以及高度知情的消费者群体。受不断变化的饮食需求和充足的产品供应推动,标准配方奶粉和专用配方奶粉的需求持续保持高位。雅培实验室、雀巢和美赞臣(利洁时)等知名企业的存在持续影响着创新週期和供应链实力,使美国成为该地区婴儿奶粉产业的基石。
塑造全球婴儿奶粉市场的关键公司包括雅培实验室、Arla Foods Amba、贝拉米有机、合生元(健合集团)和澳优乳业有限公司。为了巩固其市场地位,婴儿奶粉产业的领导者正在利用专注于产品创新、监管协调和消费者教育的策略。许多企业正在投资研发,推出添加了益生菌、有机成分和无过敏原成分的配方。各公司也致力于透过加强与电商平台、药局和医疗保健网络的合作来扩大分销范围。围绕包装和清洁标籤认证的可持续发展措施已成为关键的差异化因素,尤其是在註重健康的父母群体中。
The Global Baby Milk Market was valued at USD 16.5 billion in 2024 and is estimated to grow at a CAGR of 5.4% to reach USD 27.7 billion by 2034. This market helps in supporting infant nutrition, especially for mothers who are unable or choose not to breastfeed. The category includes various formulations such as infant formula (for babies up to 6 months), follow-on formula (6 to 12 months), growing-up milk (12 to 36 months), and specialized products developed for lactose intolerance, premature birth, and other sensitive health needs. These milk products are scientifically engineered to simulate breast milk, delivering essential nutrients such as carbohydrates, fats, proteins, vitamins, and minerals necessary for healthy growth. The market's momentum is being fueled by higher rates of working mothers, improved access to products through digital and retail platforms, and growing interest in clean-label and organic alternatives.
Evolving consumer preferences are reshaping the baby milk category, pushing companies to deliver safe, efficient, and nutrient-rich options that align with health-conscious parenting. Today's caregivers are not only looking for basic nutrition but are increasingly concerned about product transparency, clean labels, organic sourcing, and the absence of artificial additives. This shift has led manufacturers to reformulate offerings with non-GMO ingredients, probiotics for gut health, and formulas tailored to specific needs such as lactose intolerance, allergies, or premature birth. Parents are now more informed and demand products backed by clinical research and medical endorsements.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $16.5 Billion |
Forecast Value | $27.7 Billion |
CAGR | 5.4% |
The infant formula segment held a 40.2% share in 2024 and is anticipated to maintain its leadership, growing at a CAGR of 5.6% through 2034. Parents rely heavily on this segment during the initial six months of life when infants are most vulnerable and need a carefully balanced nutritional solution. These formulas are crafted to deliver complete nourishment, closely mimicking the key nutrients found in breast milk. With health awareness rising among caregivers, demand for high-quality and medically approved infant formula remains a strong driver for the category, especially in urban households.
The carbohydrates segment held a 28.1% share in 2024 and is projected to rise at a 5.5% CAGR by 2034. Lactose, the primary carbohydrate in most baby milk formulas, serves as a critical energy source and supports vital functions such as brain development and healthy gut flora. It also plays a role in enhancing calcium absorption and promoting skeletal development. While other ingredients such as proteins, vitamins, fats, and prebiotics are essential for immune defense, metabolic function, and tissue repair, carbohydrates remain central due to their foundational contribution to infant growth. Their synergistic effect with other nutrients underscores their continued prominence in product formulations.
United States Baby Milk Market generated USD 3.9 billion in 2024 and is projected to grow at a 4.4% CAGR by 2034. The U.S. benefits from a mature formula manufacturing sector, wide-scale product accessibility, and a highly informed consumer base. Demand remains consistently high for both standard and specialized formulas, driven by evolving dietary needs and strong product availability. The presence of established players such as Abbott Laboratories, Nestle, and Mead Johnson (Reckitt) continues to influence innovation cycles and supply chain strength, making the U.S. a cornerstone of the baby milk industry in the region.
Key companies shaping the Global Baby Milk Market include Abbott Laboratories, Arla Foods Amba, Bellamy's Organic, Biostime (H&H Group), and Ausnutria Dairy Corporation Ltd. To reinforce their position, leading players in the baby milk sector are leveraging strategies that focus on product innovation, regulatory alignment, and consumer education. Many are investing in R&D to introduce formulations fortified with probiotics, organic ingredients, and allergen-free components. Companies are also working to expand their distribution reach by strengthening partnerships with e-commerce platforms, pharmacies, and healthcare networks. Sustainability initiatives around packaging and clean-label certifications have become key differentiators, especially among health-conscious parents.